The NHS explains that Alzheimer's disease is believed to be driven by an abnormal build-up of two proteins, amyloid and tau. These deposits often develop around our existing brain cells, forming ...

Statins, long hailed for lowering cholesterol, might offer an unexpected benefit beyond heart health—they could help slow ...

Dr. Marty Levine explains more about the disease and the support that's available for patients. Sponsored by Optum Care Washington.

A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for repurposing in dementia prevention.

Alzheimer’s is an insidious disease, one that robs a person of their faculties slowly, erases pieces of them over time. It’s a disease that works slowly—until it works suddenly, when a ...

Medications like donanemab (Kisunla) and lecanemab (Leqembi) target amyloid plaques that build up in the brain due to Alzheimer's disease.

Still, there are trade-offs. “Adherence challenges exist with oral Alzheimer's medications as patients can forget to take their medications,” Reichelt adds.

The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less risky for patients with cognitive decline.

The early use of Blarcamesine shows promise in treating Alzheimer's, boosting Anavex's potential. Click here to read an analysis of AVXL stock now.

The number of people with Alzheimer's dementia in the U.S. exceeded 7 million for the first time, new data from the Alzheimer's Association showed. An estimated 7.2 million Americans ages 65 and ...

Brain-boosting claims are everywhere. We asked experts: What’s the most overrated strategy for protecting your brain? And what’s the one you should actually be using?

But now, a new study offers something rare in Alzheimer's, a reason for hope. A once-daily pill called blarcamesine (pronounced blar-CAM-uh-seen) may actually slow the disease’s grip. And it ...